Found 18 clinical trials
A Phase 3, Randomized, Doubleblind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents ≥ 6 to <18 Years of Age
The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to <18 years with episodic
- 0 views
- 21 Oct, 2022
- 33 locations
Cluster Headache Treatment With Rimegepant
The purpose of this research is to explore the efficacy of rimegepant as a preventative therapy for cluster headache.
- 0 views
- 07 Oct, 2022
- 1 location
A Pilot Study of Rimegepant in Moderate Plaque-type Psoriasis
The purpose of this study is to examine the use of a new investigational medication for the treatment of moderate plaque-type psoriasis. The study medication is rimegepant, an orally
- 0 views
- 16 Oct, 2022
- 1 location
A Phase 4, Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention
The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.
- 0 views
- 22 Oct, 2022
- 19 locations
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rimegepant for Migraine Prevention in Japanese Subjects
This study is being conducted to evaluate the efficacy, safety, and tolerability of rimegepant in Japanese subjects for the prevention of migraine.
- 0 views
- 21 Oct, 2022
- 31 locations
A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Chronic Rhinosinusitis With or Without Nasal Polyps
The purpose of this study is to compare the efficacy and safety of rimegepant versus placebo in the acute treatment of chronic rhinosinusitis (CRS) with and without nasal polyps.
- 0 views
- 25 Oct, 2022
- 24 locations
A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Temporomandibular Disorders (TMD)
The purpose of this study is to compare the efficacy and safety of rimegepant versus placebo in the acute treatment of Temporomandibular Disorders (TMD), which are medical conditions involving
- 0 views
- 20 Oct, 2022
- 8 locations
A Prospective, Registry Based, Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant: The Migraine Observational Nurtec Pregnancy Registry (MONITOR) (MONITOR)
The purpose of the study is to evaluate fetal, maternal, and infant outcomes through 12 months of age.
- 0 views
- 25 Oct, 2022
- 1 location
- 1
- 2